...  Biopharmaceuticals Announces a Strategic Alliance for Innovative Drug … SK Biopharmaceuticals, PKU International HealthCare Group, and Medicilon have agreed to start clinical trials following an Investigational New Drug (IND) application later this year. … authorized INDs in the U.S. SK Biopharmaceuticals has a … Read more on Financial Post Nanoparticles Treat Degenerative Eye Disease Without Eye Injections Marco A. Zarbin, a retinal surgeon at the University of Medicine & Dentistry of New Jersey, calls the nanoparticles' design sophisticated and one that could be used in other regenerative treatments for disease. One concern he has about this specific … Read ...